Recent advances on nanomaterials-based photothermal sensing systems
TrAC Trends in Analytical Chemistry,
Год журнала:
2024,
Номер
177, С. 117801 - 117801
Опубликована: Июнь 7, 2024
Язык: Английский
Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis
FEBS Open Bio,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 17, 2025
Dimethyl
fumarate
(DMF)
is
an
anti‐inflammatory
and
immunoregulatory
medication
used
to
treat
multiple
sclerosis
(MS)
psoriasis.
Its
skin
sensitization
property
precludes
its
topical
use,
which
unfortunate
for
the
treatment
of
Isosorbide
di‐(methyl
fumarate)
(IDMF),
a
novel
derivative
DMF,
was
synthesized
circumvent
this
adverse
reaction
unlock
potential
delivery,
could
be
useful
treating
psoriasis
in
subpopulation
psoriatic
MS
patients,
as
well
general
population.
Here,
we
compared
therapeutic
non‐sensitizing
with
DMF
version
Diroximel
three
skin‐
neuroinflammation
models:
lck‐GFP
zebrafish,
activated
BV‐2
murine
microglia
human
T‐lymphocyte
Jurkat
cell
line.
The
results
provide
comparative
evaluation
bioactivity
these
related
chemical
entities
models
relevant
expose
several
advantages
unique
IDMF.
Язык: Английский
Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis
Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 781 - 781
Опубликована: Март 23, 2025
Psoriasis
is
an
immune-related
disorder
that
marked
by
abnormal
thickening
of
the
skin,
rapid
multiplication
keratinocytes,
and
complex
interactions
between
immune
cells
affected
areas.
Although
psoriasis
cannot
currently
be
cured,
drugs
can
alleviate
symptoms
regulating
homeostasis
preventing
comorbidities.
There
are
many
types
to
treat
psoriasis:
small-molecule
drugs,
including
corticosteroids;
retinoids;
vitamin
D
analogs;
immunosuppressants,
such
as
glucocorticoid
ointment,
tretinoin
cream,
methotrexate
tablets,
etc.
Macromolecular
biological
Certolizumab,
Secukinumab,
Guselkumab,
etc.,
include
monoclonal
antibodies
target
various
inflammatory
signaling
pathways.
Compared
with
traditional
therapies
offer
better
targeting
lower
systemic
side
effects,
but
their
high
costs
invasive
administration
modes
constrict
widespread
use.
Spesolimab
latest
agent
used
interleukin-36
receptor
(IL-36R)
approved
for
market
use,
which
significantly
reduces
risk
general
pustular
(GPP)
flare
84%.
Additionally,
there
several
agents
interleukin-23/T
helper
17
cell
pathway
have
already
entered
Phase
II
III
clinical
trials.
At
present,
first-line
therapeutic
strategy
mild
topical
administration.
Systemic
therapy
phototherapy
preferred
treating
moderate
severe
types.
However,
current
completely
meet
needs.
More
advanced
drug
delivery
systems
optimized
effects
bioavailability
required.
Nanocarriers
emerging
proteins,
nucleic
acids,
cell-based
therapies.
In
this
review,
we
analyze
status
therapeutics
discuss
novel
diverse
well
We
also
summarize
effectiveness
different
strategies.
Язык: Английский
Scalable Drug-Mimicking Nanoplasmonic Therapy for Bradyarrhythmia in Cardiomyocytes
Nano Letters,
Год журнала:
2024,
Номер
24(36), С. 11302 - 11310
Опубликована: Авг. 30, 2024
Bradyarrhythmia
poses
a
serious
threat
to
human
health,
with
chronic
progression
causing
heart
failure
and
acute
onset
leading
sudden
death.
In
this
study,
we
develop
scalable
drug-mimicking
nanoplasmonic
therapeutic
strategy
by
introducing
gold
nanorod
(Au
NR)
mediated
near-infrared
(NIR)
photothermal
effects.
An
integrated
sensing
regulation
platform
is
established
for
in
situ
synchronized
NIR
laser
electrophysiological
property
recording.
The
Au
NR
plasmonic
enables
the
restoration
of
normal
cardiomyocyte
rhythm
from
bradyarrhythmia.
By
regulating
aspect
ratio
concentration
NRs,
as
well
intensity
time
irradiation,
precisely
optimized
effect
explore
effective
strategies.
Furthermore,
mRNA
sequencing
revealed
significant
increase
number
differentially
expressed
genes
(DEGs)
involved
activities
cardiomyocytes
following
therapy.
NR-mediated
therapy,
an
efficient
noninvasive
approach
bradyarrhythmia,
holds
profound
implications
cardiology
research.
Язык: Английский
Self-assembled hollow CuS@AuNRs/PDA nanohybrids with synergistically enhanced photothermal efficiency
Dalton Transactions,
Год журнала:
2024,
Номер
53(34), С. 14315 - 14324
Опубликована: Янв. 1, 2024
A
NIR/pH
dual-responsive
hollow
CuS@AuNRs/PDA
nanocarrier
with
synergistically
enhanced
photothermal
efficiency
was
prepared
by
electrostatic
self-assembly
method.
Язык: Английский
Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation
Frontiers in Bioscience-Landmark,
Год журнала:
2024,
Номер
29(12)
Опубликована: Дек. 5, 2024
Psoriasis
is
a
chronic
and
incurable
skin
inflammation
driven
by
an
abnormal
immune
response.
Our
study
aims
to
investigate
the
potential
of
interferon-γ
(IFN-γ)
primed
mesenchymal
stem
cells
(IMSCs)
in
targeting
T
attenuate
psoriasis-like
inflammation,
elucidate
underlying
molecular
mechanism
involved.
Mesenchymal
(MSCs)
were
isolated
from
umbilical
cord
identified
based
on
their
surface
markers.
models
established
then
treated
with
IMSCs.
Flow
cytometry
analysis
was
used
examine
cell
markers
percentages.
Indoleamine-2,3-dioxygenase
(IDO)
knocked
down
small
interfering
RNA
(siRNA)
examined
western
blot
assay.
The
proliferative
capacity
assessed
using
water-soluble
tetrazolium
salt-1(WST-1).
Additionally,
immunohistochemical
assay
determine
epidermal
thickness.
psoriasis
area
severity
index
(PASI)
scores
also
assessed.
We
observed
significant
therapeutic
efficacy
IMSCs
against
mice.
Treatment
resulted
notable
reduction
infiltration
within
psoriatic
lesions.
Furthermore,
we
demonstrated
that
mediated
upregulation
IDO
through
IFN-γ
stimulation.
In
vitro,
inhibited
proliferation,
vivo,
eliminated
when
MSCs
transfected
siRNA.
can
treat
suppressing
suppression
IDO.
Язык: Английский
Gold nanorods as biocompatible nano-agents for the enhanced photothermal therapy in skin disorders
Journal of Biomedical Research,
Год журнала:
2024,
Номер
38, С. 1 - 1
Опубликована: Янв. 1, 2024
Язык: Английский
Influence of Branched Ligand Architectures on Nanoparticle Interactions with Lipid Bilayers
Nanoscale,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 27, 2024
We
utilize
coarse-grained
molecular
dynamics
simulations
and
enhanced
sampling
methods
to
reveal
the
effect
of
ligand
branching
on
thermodynamics
nanoparticle
adsorption
lipid
bilayers.
Язык: Английский